Accueil Healthcare Psychedelic Therapeutics Market is estimated to be worth over USD 6.5 billion by 2030

Psychedelic Therapeutics Market is estimated to be worth over USD 6.5 billion by 2030


Psychedelic substances have been demonstrated to interact with a variety of neurotransmitter pathways, including those involving serotonin, acetylcholine, norepinephrine, and dopamine. Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop leads based on natural and synthetic derivatives of psychedelic substances. Further, experts believe that psychedelics, at appropriate doses, can be used to address some of the serious psychological implications associated with the COVID-19 pandemic.

Roots Analysis has announced the addition of “Global Psychedelic Therapeutics Market, 2020-2030” report to its list of offerings.

The over USD 6.5 billion (by 2030) financial opportunity within the Psychedelic Therapeutics market has been analyzed across the following segments:

Target Disease Indication

  • Anxiety and Depression
  • Trauma
  • Pain Disorder
  • Sleep related Disorder

Origin of Psychedelic Substance

  • Natural
  • Synthetic

Type of Psychedelic Substance

  • Gamma-hydroxybutyrate
  • Ketamine
  • MDMA
  • Psilocybin

Route of Administration

  • Oral
  • Intranasal
  • Sublingual

Key Geographies

  • North America
  • Europe
  • Asia-Pacific

The Global Psychedelic Therapeutics Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:

  • Celon Pharma
  • iX Biopharma
  • MAPS Public Benefit
  • MindMed
  • Janssen Pharmaceuticals
  • Jazz Pharmaceutical


Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape: Psychedelic Therapeutics

5. Company Profiles

6. Clinical Trial Analysis

7. Clinical Trial Site Analysis

9. Key Opinion Leader (KOL) Analysis

8. Academic Grants Analysis

10. Partnerships and Collaborations

11. Mergers and Acquisitions

12.  Market Forecast and Opportunity Analysis

13. Concluding Remarks

14. Executive Insights

15. Appendix 1: Tabulated Data

16. Appendix 2: List of Companies and Organizations

For more information, please click on the following link:    

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

Charger d'autres articles liés
Charger d'autres écrits par rootsanalysis
Charger d'autres écrits dans Healthcare

Laisser un commentaire

Consulter aussi

Digital Therapeutics Market is projected to be worth over USD 8.86 billion by 2030, growing at a CAGR of 19.7%

Recent advances in information technology and biomedical science have enabled the developm…